Nadjib Taouagh

Large variation in effects during 10 years of enzyme therapy in adults with Pompe disease

Laurike Harlaar, Jean‐Yves Hogrel, Barbara Perniconi et al. · Neurology · 2019 · 127 citations · Full text

Long‐term benefit of enzyme replacement therapy with alglucosidase alfa in adults with Pompe disease: Prospective analysis from the French Pompe Registry

Claudio Semplicini, Marie De Antonio, Nadjib Taouagh et al. · Journal of Inherited Metabolic Disease · 2020 · 58 citations

The French Pompe registry. Baseline characteristics of a cohort of 126 patients with adult Pompe disease

Pascal Laforêt, K. Laloui, Benjamin Granger et al. · Revue Neurologique · 2013 · 57 citations

Adult Pompe Disease, Global Health, Clinical Epidemiology +5

Late‐onset Pompe disease in France: molecular features and epidemiology from a nationwide study

Claudio Semplicini, Pascaline Létard, Marie De Antonio et al. · Journal of Inherited Metabolic Disease · 2018 · 41 citations

Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients

Elisa Masat, Pascal Laforêt, Marie De Antonio et al. · Scientific Reports · 2016 · 28 citations · Full text